TP53 and cancer: Because the ability of a mutant of p53 to suppress cancer has historically been tightly linked with a specific capacity to drive the expression of transcriptional targets, we characterized the transactivation potential of cDNAs of these mutants in human cells and confirmed that p53E224D retained transactivation.